As a public service to our readership, this article - peer reviewed by the Editors of EuroIntervention - has been published immediately upon acceptance as it was received. The content of this article is the sole responsibility of the authors, and not that of the journal or its publishers. To read the full content of this article, please download the PDF.
Sign in to download the full article
Holger Eggebrecht1; Kurt Bestehorn2; Tienush Rassaf3; Maike Bestehorn4; Thomas Voigtländer5; Eckhard Fleck6; Volker Schächinger7; Axel Schmermund8; Rajendra H Mehta9;
1. Cardioangiologisches Centrum Bethanien (CCB) and Agaplesion Bethanien Hospital, Frankfurt, Germany, GERMANY; 2. Technical University of Dresden, Dresden, Germany; 3. Department of Cardiology and Vascular Medicine, Medical Faculty, West German Heart and Vascular Center, University Hospital Essen, Essen, Germany; 4. ProMedCon GmbH, Ebenhausen, Germany; 5. Cardioangiologisches Centrum Bethanien (CCB) and AGAPLESION Bethanien Hospital, Frankfurt, Germany; 6. German Cardiac Society, Düsseldorf/Berlin, Germany; 7. Klinikum Fulda, Medizinische Klinik I, Fulda, Germany; 8. Cardioangiologisches Centrum Bethanien (CCB) and AGAPLESION Bethanien Hospital, Frankfurt, Germany; 9. Duke Clinical Research Institute and Duke University Medical Center, Durham, NC, USA
Aims: Randomised trials comparing transcatheter aortic valve replacement (TAVR) with surgical aortic valve replacement (SAVR) have included mainly elderly patients >80 years. The authors investigated comparative in-hospital outcomes of younger patients <75 years undergoing transfemoral (tf) tavr or isolated savr.
Methods and results: A total of 6,972 pa…